Medium-Chain Triglycerides (MCT Oil) per Gut Dysbiosis

In vitro evidence for caprylic acid against Candida. Very limited clinical evidence for GI Candida overgrowth.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dmedium\u002Dchain\u002Dtriglycerides\u0026condition\u003Dgut\u002Ddysbiosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

In sintesi

In vitro evidence for caprylic acid against Candida. Very limited clinical evidence for GI Candida overgrowth.

Key Study Findings

Review

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory …

Dose: 41, G vs: None Outcome: None Effetto: None None

Popolazione: IBD patients

Key Statistics

Studi

Partecipanti

↑

Positive

Grado

Referenced Papers

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Review

Frontiers in immunology 2019 3034 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:: 5-15 mL (1-3 tablespoons) per day
malabsorptionsupport:: 15-30 mL per day in divided doses
antimicrobialprotocol:: 1-2 tablespoons per day (caprylic acid-rich MCT)

Limite massimo: Not established; doses above 30 mL/day commonly cause GI distress

Dosaggi studiati nella ricerca

Dosaggio	Durata	Effetto	N
41, G	--	Mixed	--

Momento migliore per l'assunzione: With meals; start with small doses (1 teaspoon) and increase gradually

Safety & Side Effects

Effetti collaterali segnalati

⚠ Diarrhea and loose stools (most common, especially when starting; titrate dose up slowly)
⚠ Nausea and abdominal cramping
⚠ Bloating
⚠ May raise LDL cholesterol in some individuals

Interazioni note

● Blood sugar-lowering medications (MCTs may affect ketone and glucose metabolism)
● Hepatotoxic medications (MCTs are metabolized in the liver; caution in liver disease)

Livello di assunzione massimo tollerabile: Not established; doses above 30 mL/day commonly cause GI distress

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Medium-Chain Triglycerides (MCT Oil) help with Gut Dysbiosis?

Based on 1 studies with 30 participants, there is preliminary evidence that needs more research that Medium-Chain Triglycerides (MCT Oil) may support Gut Dysbiosis management. Our evidence grade is D (Very Early Research).

How much Medium-Chain Triglycerides (MCT Oil) should I take for Gut Dysbiosis?

Studies have used various dosages. A commonly studied range is 5-15 mL (1-3 tablespoons) per day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Medium-Chain Triglycerides (MCT Oil)?

Reported side effects may include Diarrhea and loose stools (most common, especially when starting; titrate dose up slowly), Nausea and abdominal cramping, Bloating, May raise LDL cholesterol in some individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Medium-Chain Triglycerides (MCT Oil) and Gut Dysbiosis?

We rate the evidence as Grade D (Very Early Research). This rating is based on 1 peer-reviewed studies with 30 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Gut Dysbiosis

Inulin D Berberine D

Medium-Chain Triglycerides (MCT Oil) per altre condizioni

Bloating and Intestinal Gas C

Verdetto rapido

In vitro evidence for caprylic acid against Candida. Very limited clinical evidence for GI Candida overgrowth.

Evidence Strength30%

Low confidence

Analisi degli studi

RCT (0)Meta (0)Other (1)

Confronta le alternative

Scoprite come si confrontano altri ingredienti per questa condizione.

Visualizza tutti gli ingredienti per Gut Dysbiosis

Approfondimenti

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.